BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
1401
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $223M | 0.01% |
4,916,922
+38,577
| +0.8% | +$1.82M |
|
1402
Axsome Therapeutics
AXSM
$10.9B
| $223M | 0.01% |
2,160,246
+349,369
| +19% | +$14.1M |
|
1403
Methode Electronics
MEI
$592M
| $223M | 0.01% |
5,668,094
+100,240
| +2% | +$3.64M |
|
1404
AstraZeneca
AZN
$250B
| $223M | 0.01% |
2,231,808
+97,437
| +5% | +$9.17M |
|
1405
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $222M | 0.01% |
7,270,865
-309,358
| -4% | -$8.79M |
|
|
AL
1406
DELISTED
Air Lease Corp
AL
| $222M | 0.01% |
4,669,056
+116,625
| +3% | +$5.24M |
|
1407
La-Z-Boy
LZB
$1.69B
| $222M | 0.01% |
7,043,189
+42,316
| +0.6% | +$1.42M |
|
1408
Atlantic Union Bankshares
AUB
$5.97B
| $222M | 0.01% |
5,901,881
+54,605
| +0.9% | +$2.06M |
|
1409
Outfront Media
OUT
$5.5B
| $221M | 0.01% |
8,390,340
-1,300,918
| -13% | -$33.5M |
|
1410
Gentherm
THRM
$1.27B
| $221M | 0.01% |
4,984,771
+123,760
| +3% | +$5.27M |
|
1411
AeroVironment
AVAV
$9.45B
| $221M | 0.01% |
3,580,897
+105,438
| +3% | +$6.32M |
|
|
ECOL
1412
DELISTED
US Ecology, Inc.
ECOL
| $221M | 0.01% |
3,812,903
+591,960
| +18% | +$35.1M |
|
|
SYKE
1413
DELISTED
SYKES Enterprises Inc
SYKE
| $221M | 0.01% |
5,967,533
+31,213
| +0.5% | +$1.06M |
|
|
CVSA
1414
Covista Inc
CVSA
$4.8B
| $220M | 0.01% |
6,301,871
-181,416
| -3% | -$6.25M |
|
1415
S&T Bancorp
STBA
$1.79B
| $220M | 0.01% |
5,467,157
+386,795
| +8% | +$14.6M |
|
|
BOLD
1416
DELISTED
Audentes Therapeutics, Inc
BOLD
| $220M | 0.01% |
3,678,864
-31,951
| -0.9% | -$1.2M |
|
1417
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
| $220M | 0.01% |
2,155,461
-401,777
| -16% | -$38.6M |
|
|
ISBC
1418
DELISTED
Investors Bancorp, Inc.
ISBC
| $219M | 0.01% |
18,414,109
+387,256
| +2% | +$4.64M |
|
1419
Pediatrix Medical
MD
$2.2B
| $219M | 0.01% |
7,869,083
+237,310
| +3% | +$5.95M |
|
1420
TotalEnergies
TTE
$190B
| $218M | 0.01% |
3,945,636
+109,773
| +3% | +$5.8M |
|
1421
Universal Corp
UVV
$1.27B
| $218M | 0.01% |
3,819,926
+76,820
| +2% | +$4.15M |
|
1422
Kinsale Capital Group
KNSL
$8.51B
| $218M | 0.01% |
2,141,814
+345,445
| +19% | +$34.4M |
|
1423
Archrock
AROC
$5.8B
| $215M | 0.01% |
21,436,276
+940,291
| +5% | +$8.77M |
|
1424
Petrobras Class A
PBR.A
$103B
| $215M | 0.01% |
14,399,951
-997,383
| -6% | -$14.1M |
|
1425
Halozyme
HALO
$12.2B
| $214M | 0.01% |
12,096,797
-907,741
| -7% | -$15.7M |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.